<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03406052</url>
  </required_header>
  <id_info>
    <org_study_id>Yorku</org_study_id>
    <secondary_id>2016-115</secondary_id>
    <secondary_id>2017-154</secondary_id>
    <nct_id>NCT03406052</nct_id>
  </id_info>
  <brief_title>Smartphone-enabled Health Coaching Intervention for Youth Diagnosed With Major Depressive Disorders</brief_title>
  <official_title>An Innovative Smartphone-enabled Health Coaching Intervention for Youth Diagnosed With Major Depressive Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>York University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre for Addiction and Mental Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>York University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled trial (RCT) comparing youth diagnosed with major depressive disorder
      treated with online mindfulness-based cognitive behavioural therapy vs. standard psychiatric
      care (as wait-list controls). Eligible subjects will be recruited from the wait-lists of the
      Centre for Addiction and Mental Health. N = 168 subjects will consist of youth from First
      Nations background (18-30 yrs) and youth from all other ethnic backgrounds stratified to two
      intervention groups and two wait-list control groups consisting of 50% First Nations youth
      and 50% youth of all other ethnic backgrounds.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A high proportion (70%) of mental health problems appear before 25 yrs. and can become become
      long-standing, significant disorders that impair all life domains. Early signs of disorder
      left untreated is an acute problem for Canadian youth as 15-25 yrs is the most likely
      age-strata for diagnosable psychiatric disorders, substance dependencies and suicide.
      Progress in youth treatments that engage the tendencies of youth to respond to online
      internet contact are likely to be especially strategic.

      In this randomized controlled trial (RCT) diagnosed depressed youth are treated with online
      mindfulness-based cognitive behavioural therapy (MB-CBT) and standard psychiatric care or
      just standard psychiatric care (as wait-list controls). Eligible subjects will be recruited
      from the wait-lists of the Centre for Addiction and Mental Health (CAMH), and from
      community-based practices and clinics proximal to CAMH. The consented 168 subjects will be
      from First Nations background (18-30 yrs) and from all other ethnic backgrounds, stratified
      into two intervention groups and two wait-list control groups.

      Primary outcome is self reported depression using the Beck Depression Inventory II while
      secondary outcomes include self reported anxiety (Beck Anxiety Inventory), depression (Quick
      Inventory of Depressive Symptomatology, 24-item Hamilton Rating Scale for Depression
      (HRSD-24)), pain (Brief Pain Inventory) mindfulness (Five-Facet Mindfulness Questionnaire)
      and intervention costs.

      If hypotheses are confirmed that youth can be effectively treated with online MB-CBT at
      reduced costs, effective treatment can be delivered to greater numbers with less geographic
      restriction.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 19, 2018</start_date>
  <completion_date type="Anticipated">March 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Psychiatrists providing psychiatric care will be blinded to the group allocation of subjects under their treatment. One outcome assessor (who will conduct the 24-item Hamilton Rating Scale for Depression (HRSD-24) will be blinded. Investigators will be blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Beck Depression Inventory II</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Change from baseline self report of symptoms of depression</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Beck Anxiety Scale</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Change from baseline self report of anxiety symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quick Inventory of Depressive Symptomatology</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Change from baseline self report of symptoms of depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hamilton Depression Rating Scale (HRDS-24)</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Change from baseline interview and interviewer rating of symptoms of depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Five-Facet Mindfulness Questionnaire</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Change from baseline self report of mindfulness experience</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brief Pain Inventory</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Change from baseline self report of pain intensity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">168</enrollment>
  <condition>Disorder, Major Depressive</condition>
  <arm_group>
    <arm_group_label>Smartphone-Assisted MB-CBT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Online intervention accessed through smartphone or online accessed computer comprised of Mindfulness-Based Cognitive Behaviour content</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard psychiatric care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Smartphone-Assisted MB-CBT</intervention_name>
    <description>Experimental subjects will receive a mindfulness-based CBT online software program workbook (in collaboration with Nex J Systems, Inc.) accessible online. Exposure to and interaction with the online workbook is combined with health coaching (duration of 24 total hours) primarily delivered in phone and software interactions. In addition, each participant will be given a Fitbit-HR Charge, a wearable bracelet that assesses physical steps and 24 hour heart rate in 5 second (averaged) durations (with related access to software that permits daily tracking).</description>
    <arm_group_label>Smartphone-Assisted MB-CBT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  18-30 yrs

          -  First Nations background or other ethnicity

          -  BDI-II at mild-moderate levels (i.e., BDI-II score ≥ 14 and &lt; 29 )

          -  diagnosis of major depressive disorder

          -  fluent in english

          -  diagnosis by a CAMH physician and diagnosis confirmed by a MINI International
             Neuropsychiatric Interview

        Exclusion Criteria

          -  &lt; 18 yrs and &gt; 30 yrs

          -  BDI-II in severe range ≥ 29 or &lt; 14

          -  does not qualify for diagnosis of major depressive disorder or diagnosis not confirmed
             by MINI International Neuropsychiatric Interview
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul G Ritvo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>York University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul G Ritvo, PhD</last_name>
    <phone>416-736-2100</phone>
    <phone_ext>22396</phone_ext>
    <email>pritvo@yorku.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zafiris J Daskalakis, MD,PhD</last_name>
    <phone>416-535-8501</phone>
    <phone_ext>34319</phone_ext>
    <email>Jeff.Daskalakis@camh.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre for Addiction and Mental Health</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6J 1H4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeff Daskalakis, MD,PhD</last_name>
      <phone>4165358501</phone>
      <phone_ext>4319</phone_ext>
      <email>jeff.daskalakis@camh.ca</email>
    </contact>
    <contact_backup>
      <last_name>Tania Jain, MSc</last_name>
      <phone>4165358501</phone>
      <phone_ext>36347</phone_ext>
      <email>tania.jain@camh.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Guglietti CL, Daskalakis ZJ, Radhu N, Fitzgerald PB, Ritvo P. Meditation-related increases in GABAB modulated cortical inhibition. Brain Stimul. 2013 May;6(3):397-402. doi: 10.1016/j.brs.2012.08.005. Epub 2012 Sep 7.</citation>
    <PMID>23022436</PMID>
  </results_reference>
  <results_reference>
    <citation>Radhu N, Daskalakis ZJ, Guglietti CL, Farzan F, Barr MS, Arpin-Cribbie CA, Fitzgerald PB, Ritvo P. Cognitive behavioral therapy-related increases in cortical inhibition in problematic perfectionists. Brain Stimul. 2012 Jan;5(1):44-54. doi: 10.1016/j.brs.2011.01.006. Epub 2011 Feb 5.</citation>
    <PMID>22037137</PMID>
  </results_reference>
  <results_reference>
    <citation>Wayne N, Perez DF, Kaplan DM, Ritvo P. Health Coaching Reduces HbA1c in Type 2 Diabetic Patients From a Lower-Socioeconomic Status Community: A Randomized Controlled Trial. J Med Internet Res. 2015 Oct 5;17(10):e224. doi: 10.2196/jmir.4871.</citation>
    <PMID>26441467</PMID>
  </results_reference>
  <results_reference>
    <citation>Azam MA, Katz J, Fashler SR, Changoor T, Azargive S, Ritvo P. Heart rate variability is enhanced in controls but not maladaptive perfectionists during brief mindfulness meditation following stress-induction: A stratified-randomized trial. Int J Psychophysiol. 2015 Oct;98(1):27-34. doi: 10.1016/j.ijpsycho.2015.06.005. Epub 2015 Jun 25.</citation>
    <PMID>26116778</PMID>
  </results_reference>
  <results_reference>
    <citation>Arpin-Cribbie C, Irvine J, Ritvo P. Web-based cognitive-behavioral therapy for perfectionism: a randomized controlled trial. Psychother Res. 2012;22(2):194-207. doi: 10.1080/10503307.2011.637242. Epub 2011 Nov 28.</citation>
    <PMID>22122217</PMID>
  </results_reference>
  <results_reference>
    <citation>Azam MA, Katz J, Mohabir V, Ritvo P. Individuals with tension and migraine headaches exhibit increased heart rate variability during post-stress mindfulness meditation practice but a decrease during a post-stress control condition - A randomized, controlled experiment. Int J Psychophysiol. 2016 Dec;110:66-74. doi: 10.1016/j.ijpsycho.2016.10.011. Epub 2016 Oct 18.</citation>
    <PMID>27769879</PMID>
  </results_reference>
  <results_reference>
    <citation>Pludwinski S, Ahmad F, Wayne N, Ritvo P. Participant experiences in a smartphone-based health coaching intervention for type 2 diabetes: A qualitative inquiry. J Telemed Telecare. 2016 Apr;22(3):172-8. doi: 10.1177/1357633X15595178. Epub 2015 Jul 21.</citation>
    <PMID>26199275</PMID>
  </results_reference>
  <results_reference>
    <citation>Croarkin PE, Levinson AJ, Daskalakis ZJ. Evidence for GABAergic inhibitory deficits in major depressive disorder. Neurosci Biobehav Rev. 2011 Jan;35(3):818-25. doi: 10.1016/j.neubiorev.2010.10.002. Epub 2010 Oct 12. Review.</citation>
    <PMID>20946914</PMID>
  </results_reference>
  <results_reference>
    <citation>Levinson AJ, Fitzgerald PB, Favalli G, Blumberger DM, Daigle M, Daskalakis ZJ. Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry. 2010 Mar 1;67(5):458-64. doi: 10.1016/j.biopsych.2009.09.025. Epub 2009 Nov 17.</citation>
    <PMID>19922906</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2017</study_first_submitted>
  <study_first_submitted_qc>January 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2018</study_first_posted>
  <last_update_submitted>January 19, 2018</last_update_submitted>
  <last_update_submitted_qc>January 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>York University</investigator_affiliation>
    <investigator_full_name>Paul Ritvo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

